ABBVIE INC (ABBV) Fundamental Analysis & Valuation

NYSE:ABBV • US00287Y1091

230.28 USD
-2.07 (-0.89%)
Last: Mar 6, 2026, 03:54 PM

This ABBV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

ABBV gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 520 industry peers in the Biotechnology industry. While ABBV has a great profitability rating, there are some minor concerns on its financial health. ABBV scores decently on growth, while it is valued quite cheap. This could make an interesting combination. ABBV also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

7

1. ABBV Profitability Analysis

1.1 Basic Checks

  • ABBV had positive earnings in the past year.
  • In the past year ABBV had a positive cash flow from operations.
  • ABBV had positive earnings in each of the past 5 years.
  • In the past 5 years ABBV always reported a positive cash flow from operatings.
ABBV Yearly Net Income VS EBIT VS OCF VS FCFABBV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.12%, ABBV belongs to the top of the industry, outperforming 88.85% of the companies in the same industry.
  • ABBV's Return On Invested Capital of 14.42% is amongst the best of the industry. ABBV outperforms 96.15% of its industry peers.
  • ABBV had an Average Return On Invested Capital over the past 3 years of 12.12%. This is significantly below the industry average of 19.05%.
  • The 3 year average ROIC (12.12%) for ABBV is below the current ROIC(14.42%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROIC 14.42%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ABBV Yearly ROA, ROE, ROICABBV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100

1.3 Margins

  • ABBV has a better Profit Margin (6.84%) than 89.42% of its industry peers.
  • ABBV's Profit Margin has declined in the last couple of years.
  • ABBV has a better Operating Margin (34.23%) than 96.73% of its industry peers.
  • ABBV's Operating Margin has improved in the last couple of years.
  • The Gross Margin of ABBV (71.62%) is better than 82.50% of its industry peers.
  • In the last couple of years the Gross Margin of ABBV has remained more or less at the same level.
Industry RankSector Rank
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
ABBV Yearly Profit, Operating, Gross MarginsABBV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

4

2. ABBV Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ABBV is creating value.
  • The number of shares outstanding for ABBV remains at a similar level compared to 1 year ago.
  • ABBV has about the same amout of shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ABBV has a worse debt to assets ratio.
ABBV Yearly Shares OutstandingABBV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ABBV Yearly Total Debt VS Total AssetsABBV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • An Altman-Z score of 2.48 indicates that ABBV is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ABBV has a Altman-Z score of 2.48. This is in the better half of the industry: ABBV outperforms 66.35% of its industry peers.
  • The Debt to FCF ratio of ABBV is 3.79, which is a good value as it means it would take ABBV, 3.79 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.79, ABBV belongs to the top of the industry, outperforming 92.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Altman-Z 2.48
ROIC/WACC1.81
WACC7.96%
ABBV Yearly LT Debt VS Equity VS FCFABBV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • ABBV has a Current Ratio of 0.67. This is a bad value and indicates that ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of ABBV (0.67) is worse than 88.85% of its industry peers.
  • ABBV has a Quick Ratio of 0.67. This is a bad value and indicates that ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ABBV has a Quick ratio of 0.56. This is amonst the worse of the industry: ABBV underperforms 89.42% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.56
ABBV Yearly Current Assets VS Current LiabilitesABBV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

4

3. ABBV Growth Analysis

3.1 Past

  • The earnings per share for ABBV have decreased by -1.19% in the last year.
  • The Earnings Per Share has been decreasing by -0.99% on average over the past years.
  • ABBV shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.57%.
  • Measured over the past years, ABBV shows a small growth in Revenue. The Revenue has been growing by 5.95% on average per year.
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.77% on average over the next years. This is quite good.
  • ABBV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.33% yearly.
EPS Next Y45.22%
EPS Next 2Y27.48%
EPS Next 3Y21.41%
EPS Next 5Y14.77%
Revenue Next Year10.06%
Revenue Next 2Y9.25%
Revenue Next 3Y8.61%
Revenue Next 5Y6.33%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
ABBV Yearly Revenue VS EstimatesABBV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
ABBV Yearly EPS VS EstimatesABBV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

7

4. ABBV Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 23.03 indicates a rather expensive valuation of ABBV.
  • Based on the Price/Earnings ratio, ABBV is valued cheaply inside the industry as 93.27% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.69. ABBV is around the same levels.
  • The Price/Forward Earnings ratio is 15.86, which indicates a correct valuation of ABBV.
  • Based on the Price/Forward Earnings ratio, ABBV is valued cheaply inside the industry as 95.77% of the companies are valued more expensively.
  • ABBV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.79.
Industry RankSector Rank
PE 23.03
Fwd PE 15.86
ABBV Price Earnings VS Forward Price EarningsABBV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ABBV indicates a rather cheap valuation: ABBV is cheaper than 94.23% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, ABBV is valued cheaper than 94.81% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.84
EV/EBITDA 16.18
ABBV Per share dataABBV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • ABBV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ABBV has a very decent profitability rating, which may justify a higher PE ratio.
  • ABBV's earnings are expected to grow with 21.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y27.48%
EPS Next 3Y21.41%

7

5. ABBV Dividend Analysis

5.1 Amount

  • ABBV has a Yearly Dividend Yield of 3.08%. Purely for dividend investing, there may be better candidates out there.
  • ABBV's Dividend Yield is rather good when compared to the industry average which is at 1.19. ABBV pays more dividend than 99.04% of the companies in the same industry.
  • ABBV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.08%

5.2 History

  • On average, the dividend of ABBV grows each year by 6.76%, which is quite nice.
  • ABBV has paid a dividend for at least 10 years, which is a reliable track record.
  • ABBV has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)6.76%
Div Incr Years11
Div Non Decr Years11
ABBV Yearly Dividends per shareABBV Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • ABBV pays out 278.48% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of ABBV is growing, but earnings are growing more, so the dividend growth is sustainable.
DP278.48%
EPS Next 2Y27.48%
EPS Next 3Y21.41%
ABBV Yearly Income VS Free CF VS DividendABBV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B
ABBV Dividend Payout.ABBV Dividend Payout, showing the Payout Ratio.ABBV Dividend Payout.PayoutRetained Earnings

ABBV Fundamentals: All Metrics, Ratios and Statistics

ABBVIE INC

NYSE:ABBV (3/6/2026, 3:54:10 PM)

230.28

-2.07 (-0.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-04
Earnings (Next)04-23
Inst Owners75.04%
Inst Owner Change2.19%
Ins Owners0.05%
Ins Owner Change11.83%
Market Cap406.99B
Revenue(TTM)61.16B
Net Income(TTM)4.19B
Analysts77.3
Price Target255.68 (11.03%)
Short Float %1.3%
Short Ratio3.35
Dividend
Industry RankSector Rank
Dividend Yield 3.08%
Yearly Dividend6.6
Dividend Growth(5Y)6.76%
DP278.48%
Div Incr Years11
Div Non Decr Years11
Ex-Date04-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.46%
Min EPS beat(2)0.18%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.25%
Min EPS beat(4)0.18%
Max EPS beat(4)2.75%
EPS beat(8)8
Avg EPS beat(8)1.12%
EPS beat(12)10
Avg EPS beat(12)0.74%
EPS beat(16)12
Avg EPS beat(16)0.58%
Revenue beat(2)0
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)-0.78%
Revenue beat(4)2
Avg Revenue beat(4)0.07%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)5
Avg Revenue beat(12)0.03%
Revenue beat(16)5
Avg Revenue beat(16)-0.64%
PT rev (1m)2.41%
PT rev (3m)2.85%
EPS NQ rev (1m)-3.73%
EPS NQ rev (3m)-1.78%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.06%
Revenue NQ rev (1m)-1.75%
Revenue NQ rev (3m)-1.02%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)1.17%
Valuation
Industry RankSector Rank
PE 23.03
Fwd PE 15.86
P/S 6.65
P/FCF 22.84
P/OCF 21.39
P/B N/A
P/tB N/A
EV/EBITDA 16.18
EPS(TTM)10
EY4.34%
EPS(NY)14.52
Fwd EY6.31%
FCF(TTM)10.08
FCFY4.38%
OCF(TTM)10.77
OCFY4.68%
SpS34.6
BVpS-1.85
TBVpS-51.8
PEG (NY)0.51
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 3.12%
ROE N/A
ROCE 23.09%
ROIC 14.42%
ROICexc 15.28%
ROICexgc N/A
OM 34.23%
PM (TTM) 6.84%
GM 71.62%
FCFM 29.13%
ROA(3y)3.28%
ROA(5y)5.23%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)12.12%
ROIC(5y)11.88%
ROICexc(3y)13.19%
ROICexc(5y)12.96%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.1%
ROCE(5y)18.64%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.79%
ROICexc growth 5Y14.56%
OM growth 3Y-0.41%
OM growth 5Y2.75%
PM growth 3Y-30.39%
PM growth 5Y-7.2%
GM growth 3Y0.04%
GM growth 5Y1.44%
F-Score8
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 3.79
Debt/EBITDA 2.11
Cap/Depr 14.92%
Cap/Sales 1.98%
Interest Coverage 6.97
Cash Conversion 65.45%
Profit Quality 425.61%
Current Ratio 0.67
Quick Ratio 0.56
Altman-Z 2.48
F-Score8
WACC7.96%
ROIC/WACC1.81
Cap/Depr(3y)11.82%
Cap/Depr(5y)10.58%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.55%
Profit Quality(3y)434.7%
Profit Quality(5y)340.33%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.19%
EPS 3Y-10.33%
EPS 5Y-0.99%
EPS Q2Q%25.46%
EPS Next Y45.22%
EPS Next 2Y27.48%
EPS Next 3Y21.41%
EPS Next 5Y14.77%
Revenue 1Y (TTM)8.57%
Revenue growth 3Y1.75%
Revenue growth 5Y5.95%
Sales Q2Q%10.04%
Revenue Next Year10.06%
Revenue Next 2Y9.25%
Revenue Next 3Y8.61%
Revenue Next 5Y6.33%
EBIT growth 1Y26.92%
EBIT growth 3Y1.33%
EBIT growth 5Y8.87%
EBIT Next Year42.03%
EBIT Next 3Y19.48%
EBIT Next 5Y10.36%
FCF growth 1Y-0.09%
FCF growth 3Y-9.76%
FCF growth 5Y1.19%
OCF growth 1Y1.19%
OCF growth 3Y-8.62%
OCF growth 5Y1.59%

ABBVIE INC / ABBV FAQ

Can you provide the ChartMill fundamental rating for ABBVIE INC?

ChartMill assigns a fundamental rating of 6 / 10 to ABBV.


What is the valuation status of ABBVIE INC (ABBV) stock?

ChartMill assigns a valuation rating of 7 / 10 to ABBVIE INC (ABBV). This can be considered as Undervalued.


Can you provide the profitability details for ABBVIE INC?

ABBVIE INC (ABBV) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for ABBV stock?

The Price/Earnings (PE) ratio for ABBVIE INC (ABBV) is 23.03 and the Price/Book (PB) ratio is -124.46.


What is the expected EPS growth for ABBVIE INC (ABBV) stock?

The Earnings per Share (EPS) of ABBVIE INC (ABBV) is expected to grow by 45.22% in the next year.